Attached is a 'Covid Christmas' themed stamp on a card I received from Ireland.
The Ministry of Health, informs that a 32 year old doctor, who received the COVID-19 vaccine from Pfizer-BioNTech, is hospitalized in the intensive care unit of a high specialty hospital attached to the Mexican Institute of Social Security in the state of Nuevo Leon, after she presented a skin rash, convulsions, decreased muscle strength and respiratory difficulty, within the next half hour after the application. The reaction was detected within the specific observation area of the vaccination cell where the doctor received her vaccine.
In this regard, the Secretariat informs that it is already studying the case to know the direct cause of the picture presented by the doctor. The initial diagnosis is encephalomyelitis in study, it is reported stable, without presence of convulsive crisis in the last hours.
The doctor has a history of allergy to Trimetroprim with sulfamethoxazole, which can cause serious conditions and even death and is characterized, among other things, by skin rashes, angioedema and anaphylactic reaction.
With the scientific evidence available from the clinical trials of the Pfizer-BioNTech BNT162b2 vaccine against SARS-CoV-2, no person had ever presented encephalitis after the application of the vaccine.
Health authorities represented by the General Direction of Epidemiology and the National Center for the Health of Children and Adolescents (Censia) are investigating the case together with the Mexican Institute of Social Security (IMSS), under the protocol ESAVI: Supposedly Attributable Events to Vaccination and Immunization, established by the Federal Commission for the Protection against Sanitary Risks (Cofepris).
The doctor is under observation and treatment by specialists in critical medicine to diminish the presented brain inflammation. Intensive specialized treatment based on steroids and anticonvulsants will be continued to reduce the risk of presenting sequelae.
Translated with www.DeepL.com/Translator (free version)
COVID-19 Vaccine Trial Volunteer in India Develops Encephalopathy
First transverse myelitis (inflammation of the spinal cord), now this. AstraZeneca/Oxford claim no correlations with the vaccine trials in both cases. In the case above, the person is being sued for claiming vaccine injury.
If there are correlations between things like encephalopathy, transverse myelitis, and the vaccine, they should become apparent as Covishield is rolled out. At the same time, it appears that the vaccine does little to nothing as far as protecting one from covid.
COVID-19 Vaccine Trial Volunteer in India Develops Encephalopathy..
(Note: According to Phizer.. interaction studies with other drugs & vaccines have not been performed.) A 40-year old business consultant in India, who volunteered to be a participant in clinica…healthandmoneynews.wordpress.com
"Here's looking at you, Covid!"Attached is a 'Covid Christmas' themed stamp on a card I received from Ireland.
That's what I'm calling s strong start of the New Year!~West Virginia health officials mistakenly gave 42 people Regeneron IV Covid treatment instead of vaccine shot
95% efficacy
Hundreds of Israelis get infected with Covid-19 after receiving Pfizer/BioNTech vaccine – reports
With the vaccine not providing immediate immunity to the coronavirus, over two hundred Israeli citizens have been diagnosed with the disease days after getting the Pfizer/BioNTech jabs, local media reported.www.rt.com
Absolute attempted murder.First case of severe reaction in Mexico
001. The Ministry of Health studies the case of the doctor who presented a clinical reaction after the vaccination against COVID-19
Also for Pfizer it seems
This 95% efficacy claimed by Pfizer has to be taken with a grain salt.
First, this a figure stated by Pfizer only, although the results of the clinical trial have been finally published in a peer-reviewed journal, the clinical trials have not been replicated yet.
Second, even if this 95% efficacy figure is true (which I doubt) the protocol of the Pfizer clinical trials had one primary objective: evaluate the frequency of mild to severe forms of covid 28 days after the administration of the vaccine. Casualty rate, transmissibility rate or even occurrence of mild to severe forms in the short term (less than 28 days) or in the long term (more than 28 days) were not primarily investigated.
Third, testing a vaccine against a placebo makes sense when the targeted disease has no known cure. But in the case of covid-19, there is known cures including hydroxychloroquine which results have been tested in 179 published papers out of which 166 confirmed the real efficacy (not the Pfizer pseudo efficacy) against covid-19. Interestingly, 11 of the 13 papers that denied the efficacy of HCQ have investigators funded by Gilead. So, the vaccines should be tested against HCQ not placebo.
Fourth, Pfizer tested its vaccine on "positive cases" (probably including a lot of false positives) and without mentioning any specific variant while Raoult and others have identified at least half a dozen variants of SARS-CoV-2.
Fifth, the limited cohort (about 30,000 participants) selected by Pfizer does not exhibit all the age/race/sex/disease/treatment /genetic profile combinations that the general population does. It adds one more bias to the "efficacy" claims (and to the side effects claims)
For the reasons exposed above, the 95% efficacy rate claimed by Pfizer is pure marketing baloney.
First, a relative risk reduction is being reported, not absolute risk reduction, which appears to be less than 1%.
11 of the 13 papers that denied the efficacy of HCQ have investigators funded by Gilead.
Yeah, their whole study has to be taken with a grain of salt. It's ridiculously biased. A few additional points to consider (as mentioned by a Dutch neurologist):This 95% efficacy claimed by Pfizer has to be taken with a grain salt.
Jeroen Pols, the lawyer of the Virus Truth action group, has won interlocutory proceedings against the Dutch State. He demanded that the Netherlands should not ask that his wife and children first undergo a PCR test and show a negative test result before a return trip to the Netherlands.
In case if someone want to do some "number crunching" by himself, Wodarg was reffering to this comment on BMJ:German Dr Wodarg
said it already several weeks ago: that the amount of risk reduction of the Pfizer/BioNTech “vaccine” is equivalent to 0.35% according to their “trial” claiming 95%. But one you dig into the numbers.
if you have 300 people getting vaccinated it may benefit one with “covid-19” - but the remaining 299 will not benefit at all BUT have to carry all the risks that the vaccine poses. Which are considerable as we now slowly start to witness.
So. Equivalent to a futile 0.35% risk reduction.
Such a number is at all levels unacceptable to be touted as a vaccine (from official medical and practical perspective from the past)
Because those need to be at least 15% or more to begin with (which it is the case for annual flu vaccines)
In my personal opinion even that is close to bs.
And such are the games of numbers.
* rolling my eyes*
(...) Specific data are not given but it is easy enough to approximate the numbers involved, based on the 94 cases in a trial that has enrolled about 40,000 subjects: 8 cases in a vaccine group of 20,000 and 86 cases in a placebo group of 20,000. This yields a Covid-19 attack rate of 0.0004 in the vaccine group and 0.0043 in the placebo group. Relative risk (RR) for vaccination = 0.093, which translates into a “vaccine effectiveness” of 90.7% [100(1-0.093)]. This sounds impressive, but the absolute risk reduction for an individual is only about 0.4% (0.0043-0.0004=0.0039). The Number Needed To Vaccinate (NNTV) = 256 (1/0.0039), which means that to prevent just 1 Covid-19 case 256 individuals must get the vaccine; the other 255 individuals derive no benefit, but are subject to vaccine adverse effects, whatever they may be and whenever we learn about them…
In case if someone want to do some "number crunching" by himself, Wodarg was reffering to this comment on BMJ: